Nervous Disorder TRIZ Cases

Distinct crystalline forms of a pyridazinone inhibitor reduce protein leakage and lower relapse rates in kidney disease treatment.

Epithelial-mesenchymal transition generates renewable progenitor cells, resolving the contradiction between sufficient quantity and controlled differentiation.

Segmented amantadine dosage form combines immediate and extended release components to reduce dosing frequency and improve patient compliance.

Segmenting Nav1.9 channels with specific antibodies prevents cardiotoxicity from non-selective sodium inhibition.

Chemical synthesis of DNA dendrimers resolves high production costs from biological replication while maintaining structural integrity.

Biodegradable particles internalized within cells release active agents to control cell fate without genetic modification.

Overexpressing cognate tRNA compensates for defective synthetase activity, treating missense mutations that microRNA knockdown cannot target.

Isotopic substitution of hydrogen with deuterium improves pharmacokinetic properties and striatal dopamine levels despite increased manufacturing complexity.

Compound KC-8 prodrug mitigates opioid misuse by regulating oxycodone release through enzyme cleavage and trypsin inhibition.

Antibodies bind Oncostatin M to block gp130 receptor interaction, reducing inflammation and bone erosion in chronic diseases.

Human-derived monoclonal antibodies neutralize Nogo-A inhibitory activity, reducing immunogenicity and enhancing therapeutic stability.

Combines pilocarpine and methimazole to reduce PMP22 expression in Schwann cells, addressing insufficient efficacy of monotherapies.

Expression cassette encoding bivalent binding members for sustained secretion of therapeutic antibodies within the brain.

Beta-hydroxy-beta-methylbutyrate composition modulates autophagy to resolve ineffective cellular recycling in muscle atrophy.

Oral ketogenic diet with specific lipid ratios improves sensorimotor function while maintaining palatability.

N-heteroaryl indazoles inhibit LRRK2 kinase activity, addressing the lack of effective therapies for Parkinson's disease.

pH-dependent peptides selectively target upper GI GC-C receptors to improve motility without causing lower tract diarrhea.

An ingestible device detects physiological signals and releases anti-anxiety medication automatically.

PEG carrier improves magnesium biodistribution at spinal cord injury sites, reducing secondary damage and promoting neurological recovery.

AC-11 extract improves attention and memory in healthy adults, addressing the lack of effective methods for enhancing cognition beyond normal function.

A biodegradable subcutaneous implant embeds cannabis extracts in a polymeric matrix to deliver sustained pharmacological release.

Purification removes delta-9-tetrahydrocannabinol contaminants from synthetic cannabidiol, resolving purity versus availability trade-offs.

1-naphthol-3,6,8-trisulphonic acid selectively inhibits protein kinase C zeta without affecting other isoforms to reverse long-term potentiation.

Tyrosine kinase inhibitors modulate brain inflammation to protect neurons from degeneration.

Combining lutein, zeaxanthin, and docosahexaenoic acid prevents cognitive decline while managing formulation complexity through composite material principles.

A transdermal patch delivers multiple active substances to maintain consistent plasma levels.

An intranasal sumatriptan composition uses an alkyl glycoside to bypass slow oral onset, achieving a Tmax under 30 minutes.